Today's Big Gainers: CERS, NEWS, BPOP

Biomedical products company Cerus Corporation (CERS) announced that Swissmedic, the Swiss regulat...  More »

Biomedical products company Cerus Corporation (CERS) announced that Swissmedic, the Swiss regulatory body, has approved the use of platelet components treated with the company's INTERCEPT Blood System. Shares rocketed over 69% higher Wednesday morning, on the news.  « Less